About the Authors

Felicitas Ehlen

Roles Conceptualization, Data curation, Formal analysis, Investigation, Methodology, Writing – original draft

felicitas.ehlen@charite.de

Affiliations Department of Neurology, Humboldt-Universität zu Berlin and Berlin Institute of Health, Charité-Universitätsmedizin Berlin, Berlin, Germany, Department of Psychiatry and Psychotherapy, Jüdisches Krankenhaus Berlin, Berlin, Germany

Bassam Al-Fatly

Roles Formal analysis, Writing – review & editing

Affiliation Department of Neurology, Humboldt-Universität zu Berlin and Berlin Institute of Health, Charité-Universitätsmedizin Berlin, Berlin, Germany

Andrea A. Kühn

Roles Resources, Supervision, Validation, Writing – review & editing

Affiliations Department of Neurology, Humboldt-Universität zu Berlin and Berlin Institute of Health, Charité-Universitätsmedizin Berlin, Berlin, Germany, Berlin School of Mind and Brain, Humboldt-Universität zu Berlin, Berlin, Germany, Neurocure Cluster of Excellence, Humboldt-Universität zu Berlin and Berlin Institute of Health, Charité-Universitätsmedizin Berlin, Berlin, Germany, Bernstein Center for Computational Neuroscience, Humboldt-Universität zu Berlin and Berlin Institute of Health, Charité—Universitätsmedizin Berlin, Berlin, Germany, Deutsches Zentrum für Neurodegenerative Erkrankungen, Berlin, Germany

Fabian Klostermann

Roles Conceptualization, Funding acquisition, Methodology, Project administration, Resources, Supervision, Validation, Writing – review & editing

Affiliations Department of Neurology, Humboldt-Universität zu Berlin and Berlin Institute of Health, Charité-Universitätsmedizin Berlin, Berlin, Germany, Berlin School of Mind and Brain, Humboldt-Universität zu Berlin, Berlin, Germany

Competing Interests

The authors have read the journal’s policy and have the following competing interests: AAK has received honoraria for advisory activities from Medtronic, Boston Scientific, Abbott, Ipsen and Teva. FK has received honoraria for advisory activities from CSL Behring and Theranexus. This does not alter our adherence to PLOS ONE policies on sharing data and materials. There are no patents, products in development or marketed products associated with this research to declare.